Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
In pregnancies with offspring at risk of being affected with CCAH, prenatal diagnosis and treatment should be carried out. If the CAH patient’s partner is a carrier of a severe mutation, placing the fetus at risk for CCAH, the patient should be referred to prenatal diagnosis and treatment with dexamethasone until CVS or amniocentesis is performed. The goal is to prevent virilization in 46XX fetuses.